A phase 2 study of ACP-204 in Lewy Body Dementia
Latest Information Update: 20 Jan 2025
Price :
$35 *
At a glance
- Drugs ACP 204 (Primary)
- Indications Lewy body disease
- Focus Therapeutic Use
- 20 Jan 2025 New trial record
- 14 Jan 2025 According to an Acadia Pharmaceuticals media release, trial initiation expected in the third quarter of 2025.